To provide young scholars with an active academic exchange platform for exchanging ideas with each other and influential experts in rare disease and orphan drugs, the Editorial Office of Rare Disease and Orphan Drugs Journal (RDODJ) is constructing an editorial board specifically for young editorial members. This board would be an excellent venue for young scientists to practice their editorial management skills, comment on peer work, exchange ideas, and find collaboration opportunities.
As a member of the Youth Editorial Board, you will have the chance to work alongside the current Editorial Board, which consists of world-famous scholars who are working together to build an active academic platform and promote collaboration in the field of rare disease and orphan drugs research globally. You are invited to apply for this position.
Benefits include:
1. RDODJ
RDODJ is an international, peer-reviewed journal aiming to provide a forum for scientific studies and discussion covering the important regulatory, socio-economic and human science issues related to rare diseases and orphan drugs.
RDODJ focuses on the genetics of rare diseases, diagnosis and undiagnosed rare diseases, pathophysiological mechanism, precision medicine and genome editing, drug repurposing and delivery, preclinical translational research, regulatory and practice guidelines, medico-economic, health policies and services organization and health promotion, social sciences: patients' needs or quality of life, etc.
RDODJ was founded by OAE Publishing Inc. in 2021, with the Editor-in-Chief Prof. Daniel Scherman (Director of the Rare Disease Foundation, fellow of the European Academy of Sciences, and professor of Paris University).
The first issue of RDODJ is now available online.
3. Responsibilities of a Youth Editorial Board Member
Your responsibilities will include, but are not limited to, the following:
4. Term and Evaluation of Youth Editorial Board Members
5. Applications
The RDODJ Editorial Board looks forward to receiving your application.